Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma

Melanoma Research
Susanne SteraKatharina C Kähler

Abstract

The aim was to evaluate toxicity and oncological outcome of combined stereotactic radiosurgery (SRS) and immunotherapy or targeted therapy in patients with multiple brain metastases originating from malignant melanoma. Despite the fact that both SRS and kinase inhibitors or immune checkpoint inhibitors are considered standard treatment options for this indication, the optimal combination and sequence of these modalities remains largely unknown, especially for patients with a high number of brain metastases. For this retrospective analysis, conducted in two large SRS dedicated centers, we identified patients with brain metastases from malignant melanoma and simultaneous application of immunotherapy or targeted therapy within 30 days of SRS. Forty-eight patients with a total of 250 lesions (median: 3) were treated in 65 single fraction SRS sessions from 2012 to 2018. After a median follow-up of 8.3 months (range: 1.2-43.6 months), the 6-month and 1-year overall survival rates were 75.3 and 50.8%, respectively. The local control rate at one year was 89.5%. Immunotherapy and the application of systemic treatment directly before or concomitant to SRS were both associated with improved overall survival (P=0.037 and 0.045, respectivel...Continue Reading

References

Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sanjiv S AgarwalaElaine M Rankin
Jun 27, 2009·Cancer Control : Journal of the Moffitt Cancer Center·Andrew E SloanDouglas B Einstein
Jun 8, 2010·Journal of Neurosurgery·Donald N LiewL Dade Lunsford
Feb 8, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Maria J SambadeJaniel M Shields
Apr 10, 2014·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Martin KocherMatthias Guckenberger
Jul 25, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C Gaudy-MarquesteJ J Grob
Dec 8, 2014·Seminars in Radiation Oncology·Karsten A PilonesSandra Demaria
Mar 11, 2015·International Journal of Radiation Oncology, Biology, Physics·Ana P KiessKathryn Beal
Mar 13, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M HechtL Heinzerling
Jul 8, 2015·Vaccine·Claire Vanpouille-BoxSandra Demaria
Jul 17, 2015·JAMA Oncology·Sharad GoyalHoward L Kaufman
Sep 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R DummerUNKNOWN ESMO Guidelines Committee
Sep 20, 2015·Journal of Neuro-oncology·Tina DasguptaDaphne A Haas-Kogan
Dec 30, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K A AhmedG T Gibney
Jan 6, 2017·Cancer Treatment Reviews·Stephanie G C KroezeMatthias Guckenberger
Jan 24, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William J MagnusonVeronica L Chiang
Jun 10, 2017·Nature Communications·Claire Vanpouille-BoxSandra Demaria
Sep 7, 2017·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Susanne SteraOliver Blanck
Sep 12, 2017·The New England Journal of Medicine·Jedd D WolchokJames Larkin
Jan 20, 2018·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Jaap D ZindlerAswin L Hoffmann
May 24, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I C Glitza OlivaH Tawbi
May 29, 2018·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Christos MoustakisOliver Blanck
Jun 7, 2018·Nature Reviews. Clinical Oncology·William L HwangJay S Loeffler
Jul 2, 2018·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Prashant GabaniChristopher D Abraham
Jul 22, 2018·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Frank A GiordanoFrederik Wenz
Jun 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M HechtL Heinzerling

❮ Previous
Next ❯

Citations

May 6, 2020·Radiation Oncology·Rosario MazzolaFilippo Alongi
Jun 27, 2020·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Maria-Lisa WilhelmOliver Blanck
Apr 10, 2020·Journal of Neurosurgical Sciences·Boryana M EastmanJerome J Graber
Mar 30, 2020·Journal for Immunotherapy of Cancer·Teresa AmaralUNKNOWN *German Dermatological Cooperative Oncology Group
Oct 5, 2019·International Journal of Cancer. Journal International Du Cancer·Mark P van OpijnenEllen H W Kapiteijn
Jun 10, 2021·The European Journal of Neuroscience·Vimal Patel, Jigar Shah

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.